Keyphrases
Polycythemia Vera
100%
Essential Thrombocythemia
81%
Interferon-α (IFN-α)
66%
Myelofibrosis
54%
Chronic Myeloproliferative Neoplasms
50%
Primary Myelofibrosis
48%
Myeloproliferative Neoplasms
45%
Neoplasms
32%
Interferon alpha-2b
29%
Whole Blood Transcriptional Profiling
28%
Philadelphia-negative Myeloproliferative Neoplasms
27%
T Cells
26%
Janus Kinase 2 (JAK2)
25%
JAK2V617F mutation
24%
Gene Expression Profiling
23%
Deregulation
20%
T Cell Response
20%
Disease Stage
19%
Exon 9
19%
Calreticulin
19%
JAK2V617F
16%
Human Leukocyte Antigen Genes
16%
Natural Killer Cells
14%
CD56
14%
Whole Blood
14%
Highly Sensitive
13%
Minimal Residual Disease
13%
Inflammation
13%
Programmed Death-ligand 1 (PD-L1)
12%
Regulatory T Cells
12%
Molecular Response
12%
Immune Cells
11%
High-level Expression
11%
Human Leukocyte Antigen Class II
11%
Transcriptional Profiling
11%
Human Leukocyte Antigen Class I
11%
B Cells
11%
Calreticulin mutation
11%
Immune Surveillance
10%
MHC Class II
10%
Long-term Treatment
9%
Arginase-1 (Arg-1)
9%
Healthy Individuals
9%
Cytokine Release Syndrome
9%
Defense Genes
9%
Oxidative Defense
9%
Calreticulin Gene
9%
5-gene Signature
9%
Driver mutations
9%
Molecular Profiling
9%
Biochemistry, Genetics and Molecular Biology
Essential Thrombocythaemia
67%
Gene Expression Profiling
61%
Interferon
57%
interferon
57%
T Cell
51%
Janus Kinase
38%
Exon
28%
Calreticulin
28%
Downregulation
21%
Human Leukocyte Antigen
20%
Natural Killer Cell
19%
Regulatory T Cell
19%
Immunosurveillance
17%
Immune Response
16%
Immunocompetent Cell
15%
CD4
14%
Allele
14%
Real-Time Polymerase Chain Reaction
12%
Interferon Gamma
12%
B Cell
11%
Lymphocyte
11%
Myeloid
10%
Complex Genomic Disorder
9%
Transcription Factor Nrf2
9%
Arginase
9%
Peripheral Blood Cell
9%
Memory T Cell
9%
Janus Kinase 2
9%
Genome Instability
9%
Ruxolitinib
9%
Gene Signature
9%
Dendritic Cell
9%
Principal Component Analysis
9%
Glycoprotein
9%
Thrombocyte Activation
9%
Peripheral Blood Lymphocyte
9%
CD25
8%
Hematopoietic Stem Cell
7%
Hydroxycarbamide
7%
Granulocyte
6%
Upregulation
5%
Oxidative Stress
5%
PD-L1
5%
Medicine and Dentistry
Polycythemia vera
63%
Essential Thrombocythaemia
54%
Myeloid metaplasia
38%
Myeloproliferative Neoplasm
37%
Janus Kinase
31%
Gene Expression Profiling
25%
T Cell
25%
Myelofibrosis
21%
Interferon
19%
Regulatory T Cell
16%
Disease
15%
Neoplasm
15%
Malignant Neoplasm
14%
Immunotherapy
13%
Minimal Residual Disease
11%
Immunocompetent Cell
10%
Alpha2 Interferon
10%
Arginase 1
9%
Principal Component Analysis
9%
T-Cell Response
9%
Exon
9%
Interferon Alfa
9%
Natural Killer Cell
9%
Blood Cell
9%
Calreticulin
9%
Molecular Profiling
9%
Immunosurveillance
9%
Dendritic Cell
9%
Recombinant Alpha Interferon
9%
Recombinant Alpha2 Interferon
9%
Carcinoembryonic Antigen Related Cell Adhesion Molecule 6
9%
Latency Associated Peptide
9%
Allele
7%
Immune Response
5%
Immune System
5%
